NASDAQ: WHWK
Whitehawk Therapeutics Inc
Healthcare · Biotechnology
After hours: $4.42(0%) · as of 4:36 PM ET
Market Cap
$218.58M
52w High
$5.50
52w Low
$1.57
P/E
-2.64
Volume
574.82K
Outstanding Shares
49.45M
Price vs Fundamentals
Why The Stock Is Moving
What changed
The stock rose 115.61% over the last year. Revenue declined 100% over the trailing twelve months. Free cash flow declined 60.1% over the trailing twelve months.
What the market seems to be pricing
The stock is rising despite deteriorating fundamentals and now sits at the 95th percentile of its historical P/S range. This is a momentum-driven move — the market may be front-running a recovery that has not yet appeared in reported numbers.
What would invalidate this read
Revenue is declining 100% — a trend reversal in the next report would be the key signal to watch. This read is wrong if the next period shows operating metrics turning the corner. At that point the price would be anticipating real improvement rather than running ahead of it.
Company profile
Whitehawk Therapeutics Inc. is a biopharmaceutical enterprise currently undergoing clinical trials.
Valuation
Stock splits
Every 1 shares became 15
Profitability & growth
Analyst consensus
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Aug 6, 2026
Q3 FY26 · EPS est -$0.31 · Revenue est —
View